Protect Your Transplant Investment with Advanced HLA Antibody Screening
If you’ve undergone an organ transplant or are preparing for one, you understand the emotional and financial investment involved. The fear of rejection can be overwhelming, but early detection through our HLA DSA-SAB Class II IgG Antibodies with C1q Screen Test provides the clarity and confidence you need to protect your health journey.
Understanding Your HLA Antibody Test
This specialised test detects donor-specific antibodies (DSA) that your immune system may produce against your transplanted organ. Think of it as an early warning system – identifying potential rejection risks before they become serious problems. Using state-of-the-art Luminex X-Map technology, we achieve 99% accuracy in detecting these harmful antibodies, giving you and your medical team the precise information needed for proactive care.
Who Should Take This Critical Test?
- Pre-transplant patients: Assessing compatibility and rejection risks before surgery
- Post-transplant patients: Regular monitoring for early rejection detection
- Patients experiencing: Unexplained organ function changes or elevated creatinine levels
- Those with: Previous transplant rejection episodes or antibody-mediated complications
- Patients preparing for: Kidney, heart, liver, or other organ transplants
Why This Test Matters for Your Transplant Success
Early detection of donor-specific antibodies can mean the difference between successful long-term transplant function and rejection. This test provides:
- Early Intervention Opportunities: Detect rejection risks before irreversible damage occurs
- Treatment Guidance: Help your medical team adjust immunosuppression therapy
- Peace of Mind: Regular monitoring reduces anxiety about rejection
- Cost Savings: Prevent expensive rejection treatments and potential re-transplantation
- Improved Outcomes: Proactive management leads to better long-term transplant survival
Understanding Your Test Results
Your results will clearly indicate the presence and strength of donor-specific antibodies. Our medical team provides comprehensive explanations, and we work closely with your nephrologist or hematologist to ensure you understand what the results mean for your treatment plan. Remember: early detection means more treatment options and better outcomes.
Transparent Pricing – Investing in Your Health
| Test Description | Regular Price | Special Price | Turnaround Time |
|---|---|---|---|
| HLA DSA-SAB Class II IgG Antibodies with C1q Screen | ZAR 13,350 | 10-12 days |
This investment in early detection can save you from costly rejection treatments and preserve your transplant function.
Why Trust Oracle Genomics?
- Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
- Medical Expertise: Working with leading nephrologists and hematologists
- Advanced Technology: Luminex X-Map technology ensures 99% accuracy
- Quick Results: 10-12 day turnaround for timely decision-making
- Patient-Focused Care: Empathetic support throughout your testing journey
Take Control of Your Transplant Health Today
Don’t wait for symptoms to appear. Early detection through HLA antibody screening gives you the power to protect your transplant investment. Our team is ready to support you with:
- Easy Online Booking: Schedule your test in minutes
- Convenient Locations: Multiple collection points nationwide
- Expert Guidance: Clear explanations and result interpretation
- Insurance Support: Assistance with medical aid claims
Book your HLA antibody screening today at ZAR 13,350 and take the first step toward transplant peace of mind.
Test Preparation Requirements
Sample Required: 2 mL (1 mL minimum) serum from 1 SST tube. Ship refrigerated or frozen.
Important: Please provide brief clinical history and HLA typing report of donor/donors if pre or post transplantation sample.
